Skip to main content
Equibles
ALB logo

ALB · Albemarle Corp

Track ALB — free

Use ALB with AI

Ask our own analyst here, or connect this data to the AI you already use.

Ask ALVIS about ALB

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

or use your own AI

The free Equibles MCP server lets any client query SEC filings, earnings calls, KPIs, holdings and prices directly — read-only, OAuth-secured, cited to the filing.

ChatGPT Claude Gemini
Server URL
https://mcp.equibles.com/mcp
All connection guides →
$136.15 +5.67 (+4.35%) At close · Aug 14
Market Cap
$16.04B
Shares
118.01M

Price & Indicators

Indicators
Price
Panels
Event markers
20d MA 50d MA 200d MA Earnings Filing Insider Congress Investor day
Close$136.15 Open$132.03 Day$131.65–137.32 52W close$72.58–215.62 Avg vol 30d2.2M Short int11.2M · 9.5% float · 4.7d Short vol64% Last earningsAug 6, 2026 DataJan 2020–Aug 2026 Filing10-Q · Aug 5

Up next

Next earnings call
Nov 9, 2026 Est · unconfirmed · in 12 wks
FQ3-26 quarter ends
~Sep 30, 2026 Est
Latest filing: 10-Q
filed Aug 5, 2026

AI Brief

TL;DR.

Bullish
    Bearish

      AI-generated from the earnings call and 8-K · may contain errors · not investment advice

      Ask ALVIS about this →

      Equibles Rating

      blended score · not investment advice
      Overall
      Sell
      SellHoldBuy
      Technical Neutral Momentum Weak Sentiment Bearish Fundamentals Strong Quant / Vol Very High
      Market backdrop VIX 14.3 · calm Equity put/call 0.52
      Technical
      price trend
      Neutral
      50 / 200-day cross No cross
      Price vs 200-day avg −12%
      below
      Price vs 50-day avg +1%
      above
      RSI (14) 62
      neutral
      MACD trend Positive
      52-week position 44%
      mid-range
      Volume (OBV) Confirms
      volume backs price
      Momentum
      relative strength
      Weak
      1-month return +13%
      trailing
      6-month return −23%
      trailing
      YTD return −4%
      this year
      Relative strength −37%
      vs S&P · 6-mo
      Sentiment
      smart money
      Bearish
      Trend (MA cross) No cross
      50d $135 › 200d $154 — 200d above 50d
      Institutional flow Distributing
      -7% holders QoQ · +124 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      9.48% of float · ▲ +4.3% MoM · 4.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      930 holders — mid 3-yr range
      Squeeze score 66
      elevated · 0–100
      Fundamentals
      Strong
      Revenue growth −4%
      Y/Y
      Gross margin 13%
      expanding
      EPS growth +49%
      Y/Y
      Free cash flow $692.5M
      Balance sheet $1.6B
      net debt
      Quant / Vol
      risk profile
      Very High
      Volatility 59%
      annualized · 1-yr
      Max drawdown −48%
      past year
      ATR 4.2%
      of price · 14-day

      Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.

      Guidance & track record

      Latest guidance · from the 8-K filed Aug 5, 2026
      Specialties net sales
      Specialties net sales $1.4B – $1.6B
      Specialties adjusted EBITDA
      Specialties adjusted EBITDA Non-GAAP $275M – $325M
      full-year 2026
      Capital expenditures at least $500M
      FY 2025 avg. scenario
      Net sales $4.1B – $4.3B
      Adjusted EBITDA Non-GAAP $900M – $1B
      Net sales $2.5B – $2.6B
      Adjusted EBITDA Non-GAAP $700M – $800M
      Equity in net income of unconsolidated investments (net of tax) $200M – $300M
      2021-2025 avg. scenario
      Net sales $7.5B – $7.8B
      Adjusted EBITDA Non-GAAP $4.2B – $4.4B
      Net sales $5.9B – $6.1B
      Adjusted EBITDA Non-GAAP $3.9B – $4.1B
      Equity in net income of unconsolidated investments (net of tax) $1B – $1.1B
      Q1 2026 avg. scenario
      Net sales $5.7B – $6B
      Adjusted EBITDA Non-GAAP $2.4B – $2.6B
      Net sales $4B – $4.2B
      Adjusted EBITDA Non-GAAP $2.1B – $2.3B
      Equity in net income of unconsolidated investments (net of tax) $600M – $700M
      Prior guidance period ended · from the Earnings Call filed Sep 30, 2025
      Capital expenditures · full year 2025 $600M
      Free cash flow · full year 2025 $300M – $400M
      Energy storage sales volume growth · full year 2025 at least 10%
      Cash conversion (EBITDA to operating cash flow) · full year 2025 at least 80%
      Lithium salt volumes sold on long-term agreements with floors · full year 2025 at least 45%

      Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.

      Technicals

      trend & momentum for long-term holders Neutral
      1 · 4 · 2
      50 / 200-day cross
      No cross Neutral
      Price vs 200-day avg
      −12% Bearish
      Price vs 50-day avg
      +1% Bullish
      RSI (14)
      62 Neutral
      MACD trend
      Positive Bullish
      52-week position
      44% Neutral
      Volume (OBV)
      Confirms Neutral
      Market signals — smart money & positioning
      Bearish · 2 of 6
      Trend (MA cross) No cross
      50d $135 › 200d $154 — 200d above 50d
      Institutional flow Distributing
      -7% holders QoQ · +124 funds added
      Insider flow Flat
      No net insider activity over 90 days
      Short interest Rising
      9.48% of float · ▲ +4.3% MoM · 4.7 days cover
      Volume signal Normal
      Volume near normal
      Institution breadth Steady
      930 holders — mid 3-yr range
      Price context
      position in its 52-week range
      Range low $73 Now $136 · 44% Range high $216
      vs 200-day avg -12% vs 50-day avg +1%

      Illustrative technical + ownership context — a signal mix, not investment advice.

      Key metrics

      the company's own KPIs, from written earnings releases and filings
      Metric Latest Period YoY
      Avg. Realized Price ($/kg LCE) $19.53 Q2 2026 —
      Free cash flow non-GAAP $638M Q2 2026 —
      Operating cash flow conversion non-GAAP 83% Q2 2026 —
      Sales Volume (kT LCE) 65K Q2 2026 —
      Cost and productivity improvements $40M Q1 2026 —
      Adjusted diluted loss per share attributable to common shareholders non-GAAP -$0.53 Q4 2025 —
      GAAP → non-GAAP reconciliation
      GAAP Diluted loss per share attributable to common shareholders -$3.87
      +$0.15 Non-operating pension and OPEB items
      +$3.19 Non-recurring and other unusual items
      = Adjusted diluted loss per share attributable to common shareholders -$0.53

      Figures exactly as the company stated them in writing · click a metric with a to chart its history · period links open the stating document · "filing" marks figures stated in the 10-K/10-Q · YoY needs an exactly comparable prior-year period

      Versus peers

      Specialty Chemicals — same industry group
      Open screener →
      Company Mkt cap YTD Rev growth Y/Y P/E Short % shares
      ALB
      Albemarle Corp
      this stock
      		$16.04B -3.7% -4.4% — 9.5%
      LIN
      Linde PLC
      		 $221.01B +13.2% +3.0% 30.9 1.2%
      AIQUF
      L Air Liquide SA /Fi
      		 $126.61B +4.0% — — 0.0%
      SHW
      Sherwin Williams Co
      		 $87.44B +10.8% +2.1% 33.2 2.6%
      ECL
      Ecolab Inc.
      		 $77.40B +5.2% +2.2% 37.1 1.1%

      Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding

      At a glance

      key data from every section
      Ownership
      Institutional Holders Accumulating
      Holders
      930
      % held
      110.9%
      Net QoQ
      +7.1M sh
      Top holder
      Capital World Investors
      Held Float
      View
      Held by Funds
      Fund positions
      868
      View
      Short & Settlement
      Short Interest Rising
      Shares short
      11.2M
      Days to cover
      4.7d
      Change
      +456.8K sh
      View
      Short Volume
      Short vol %
      64%
      As of
      Aug 14, 2026
      Short Total
      View
      Fails to Deliver
      FTD shares
      1.0K
      Value
      $129.7K
      As of
      Jul 14, 2026
      View
      Off-Exchange
      Off-exchange %
      44.7%
      Week of
      Jul 6, 2026
      Off-exch Lit
      View
      Smart Money
      Congressional Trades Buy
      Member
      John Boozman
      Amount
      $1.0K–$15.0K
      Traded
      May 15, 2026
      View
      Financials
      Financials
      Revenue (FY)
      $5.1B
      Net income (FY)
      $-510.6M
      EPS diluted
      $-5.76
      View
      Buybacks
      Authorized
      shares 15.0M
      Remaining
      shares 7.4M
      Spent Remaining
      View
      Filings
      SEC Filings
      Latest
      8-K
      Filed
      Aug 5, 2026
      This year
      15
      View
      Proposed Sales
      Value
      $993.3K
      Shares
      5.7K
      Filed
      Feb 20, 2026
      View
      Earnings & Events
      Earnings Calls
      Last call
      Aug 6, 2026
      View
      Investor Relations
      Latest news
      Albemarle Reports Second Quarter…
      Published
      Aug 5, 2026
      View

      Performance

      5D 20D 120D MTD YTD
      ALB +3.8% +12.7% -23.3% +15.7% -3.7%
      SPY +0.4% +4.5% +13.8% +3.9% +13.9%
      vs SPY +3.4% +8.3% -37.1% +11.8% -17.6%

      Capital returns

      Latest dividend
      $0.405 / share · ex Jun 12, 2026
      Declared · upcoming
      $0.41 / share · ex Sep 11, 2026
      Raised 1.3%
      Paid (TTM)
      $1.62 / share · 4 payouts
      Dividend yield (TTM, derived)
      1.19%
      Buyback program · as of Dec 31, 2025
      Authorized
      shares 15.00M
      Spent (derived)
      shares 7.60M
      Remaining
      shares 7.40M
      Spent Remaining

      Dividends per share over the trailing 365 days by ex-date · buyback figures as last reported in SEC filings ("spent" derived as authorized − remaining; when several programs run concurrently, authorized is their combined total per the newest filing) · components shown separately — trailing-year buyback spend isn't tracked, so no combined shareholder yield is derived.

      Key facts CIK 915913 CUSIP 012653101 13F (30d) 881 filings 849 filers Visit website Investor relations

      Report a Problem

      Category
      Description
      Email (optional, for follow-up)